AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16847400
Drug: R‐bicalutamide/HP55S 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R‐bicalutamide/HP55S 150 mg
Trial: 16847400
Drug: R‐bicalutamide/HP55S 450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R‐bicalutamide/HP55S 450 mg
Trial: 9670800
Drug: self‐exposure in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: self‐exposure in vivo with cognitive therapy
Trial: 3198362
Drug: 0.5 ml
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 ml 0.9% saline/kg body weight (control)
Trial: 30822414
Drug: Topical Epigallocatechin-3-Gallate
RxNorm normalized name: Epigallocatechin-3-gallate
DrugBank: Epigallocatechin gallate (DB12116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Epigallocatechin-3-Gallate (EGCG)
Trial: 30822414
Drug: Topical Epigallocatechin-3-Gallate
RxNorm normalized name: Epigallocatechin-3-gallate
DrugBank: Epigallocatechin gallate (DB12116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Epigallocatechin-3-Gallate (EGCG) by zonal priming
Trial: 26328470
Drug: Quercetin (162
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin (162 mg/d from onion skin extract)
Trial: 24363694
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (25 micrograms every 4 hours, up to 6 doses)
Trial: 24363694
Drug: Foley catheter
RxNorm normalized name: Bard Foley Catheter 18FR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foley catheter (18 F, inflated with 50 cc of sterile water)
Trial: 3769897
Drug: Doxapram (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxapram (3 mg kg‐1)
Trial: 3769897
Drug: Almitrine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almitrine (1 mg kg‐1)
Trial: 22575166
Drug: FLU-v low
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: FLU-v low dose (250 μg) adjuvanted
Trial: 22575166
Drug: FLU-v high
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: FLU-v high dose (500 μg) adjuvanted
Trial: 22575166
Drug: FLU-v (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FLU-v (both doses)
Trial: 22575166
Drug: FLU-v (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FLU-v (all formulations)
Trial: 15909196
Drug: CT with
RxNorm normalized name: Impact with Fiber
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT with IV contrast agent
Trial: 15909196
Drug: CT without
RxNorm normalized name: CT-179
DrugBank: CT-179 (DB17114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT without IV contrast agent
Trial: 6516811
Drug: Control (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0.25 ml 0.9% NaCl)
Trial: 29410014
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg of baricitinib
Trial: 29410014
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of baricitinib
Trial: 18690839
Drug: All lipid-lowering
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All lipid-lowering agents (LLA) use (statin and non-statin LLA)
Trial: 10574477
Drug: Growth hormone,
RxNorm normalized name: FUSION PROTEIN OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG- .BETA.)-(118-145)-PEPTIDE (1-28) WITH HUMAN SOMATOTROPIN (GROWTH HORMONE, GH) (29-219) AND TWO TANDEM COPIES OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG-.BETA.)-(118-145)- PEPTIDE (220-247
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone, oral glutamine, and high-carbohydrate-low-fat (HCLF) diet
Trial: 1830450
Drug: Enoximone 100
RxNorm normalized name: enoximone
DrugBank: Enoximone (DB04880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoximone 100 mg
Trial: 1830450
Drug: Enoximone 25
RxNorm normalized name: enoximone
DrugBank: Enoximone (DB04880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoximone 25 mg
Trial: 31483750
Drug: HPLC-MRM-IDA-EPI analytical
RxNorm normalized name: 8-epi-cyanocobalamin
DrugBank: 8-epi-Cyanocobalamin (DB14092)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPLC-MRM-IDA-EPI analytical method for detecting chemotherapy drugs
Trial: 23292545
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicine (CM)
Trial: 19019053
Drug: Wound perfusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wound perfusion with 8 mL of 0.25% bupivacaine every 5 hours
Trial: 19019053
Drug: Intravenous pethidine
RxNorm normalized name: pethidine
DrugBank: Meperidine (DB00454)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous pethidine 0.2 mg/kg on demand
Trial: 15117890
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist plus raloxifene (leuprolide acetate depot at 3.75 mg/28 days and raloxifene hydrochloride at 60 mg/day for 18 cycles)
Trial: 12200524
Drug: eformoterol Turbohaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eformoterol Turbohaler 9 microg (delivered dose)
Trial: 12200524
Drug: budesonide Turbohaler
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: budesonide Turbohaler 400 microg twice daily
Trial: 9618752
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) up to 0.25 U/kg per week in daily doses
Trial: 1837965
Drug: 0.150 mg
RxNorm normalized name: LEVOTHYROXINE SODIUM 0.150 mg ORAL TABLET [LEVOTHYROXINE SODIUM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.150 mg Desogestrel and 0.030 mg Ethinylestradiol
Trial: 1837965
Drug: 0.075 mg
RxNorm normalized name: mestranol 0.075 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.075 mg Gestoden and 0.030 mg Ethinylestradiol
Trial: 1837965
Drug: 0.250 mg
RxNorm normalized name: DIGOXIN 0.250 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.250 mg Norgestimat and 0.035 mg Ethinylestradiol
Trial: 25211767
Drug: Combination hearing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination hearing aid with noise feature activated (experimental group, n=15)
Trial: 24849708
Drug: Nintedanib 150
RxNorm normalized name: nintedanib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nintedanib 150 mg (arm A)
Trial: 24849708
Drug: Nintedanib 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nintedanib 250 mg (arm B)
Trial: 19687168
Drug: Surgery and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery and l-T(4) abstinence
Trial: 17312403
Drug: Intranasal (IN)
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal (IN) measles vaccine
Trial: 17312403
Drug: Subcutaneous (SQ)
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous (SQ) measles vaccine
Trial: 17312403
Drug: Both IN
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both IN and SQ vaccines
Trial: 8082354
Drug: Spacer device
RxNorm normalized name: E-Z Spacer Device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spacer device with inhaled beta-agonist at discharge
Trial: 8082354
Drug: Inhaled or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled or oral beta-agonists without a spacer device
Trial: 2683547
Drug: No H2
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No H2 receptor antagonist (Control)
Trial: 747177
Drug: Naltrexone 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 25 mg first-day dose
Trial: 747177
Drug: Naltrexone 100
RxNorm normalized name: naltrexone 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 100 mg first-day dose
Trial: 747177
Drug: Naltrexone 150
RxNorm normalized name: METHYLNALTREXONE 150MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 150 mg first-day dose
Trial: 747177
Drug: Naltrexone maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone maintenance regimen in Group A (5 times weekly)
Trial: 747177
Drug: Naltrexone maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone maintenance regimen in Group B (3 times weekly)
Trial: 747177
Drug: Naltrexone maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone maintenance regimen in Group C (2 times weekly)
Trial: 31987769
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (HD) group received 4 mg of folic acid daily from the first 3 months of pregnancy until the entire pregnancy.
Trial: 31987769
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (LD) group received 0.4 mg of folic acid daily from the first 3 months of pregnancy until the entire pregnancy.
Trial: 31987769
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (HD) group with compliance >50%.
Trial: 28237842
Drug: Treatment (mobile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment (mobile application)
Trial: 21248209
Drug: Conventional outpatient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional outpatient physical therapy
Trial: 9340922
Drug: Supraphysiologic magnesium
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supraphysiologic magnesium administration
Trial: 3319722
Drug: Oxiconazole cream,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxiconazole cream, applied once daily
Trial: 27575834
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) with 50 J dose
Trial: 27575834
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) with 10 J dose
Trial: 27575834
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) with 10 J and 50 J doses
Trial: 27575834
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) with 30 J dose
Trial: 24689258
Drug: Cognitive load
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive load (high load conditions with a concurrent working memory task using auditory stimuli)
Trial: 8792045
Drug: Testosterone cypionate
RxNorm normalized name: Testosterone Cypionate
DrugBank: Testosterone cypionate (DB13943)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone cypionate 300 mg/week
Trial: 8792045
Drug: Testosterone cypionate
RxNorm normalized name: Testosterone Cypionate
DrugBank: Testosterone cypionate (DB13943)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone cypionate 600 mg/week
Trial: 29079411
Drug: Capecitabine (1250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capecitabine (1250 mg/m2 orally twice daily, days 1-14, every 21 days)
Trial: 29079411
Drug: S-1 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 (40 mg/m2 orally twice daily, days 1-28, every 42 days)
Trial: 22341040
Drug: Comprehensive rehabilitation
RxNorm normalized name: Easy Care First Aid Kit - Comprehensive KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive rehabilitation programme combined with acetaminophen 1g three times a day (group B)
Trial: 20356555
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin (LH)
Trial: 20356555
Drug: Low-dose unfractionated
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose unfractionated heparin (LUFH)
Trial: 20356555
Drug: Low-dose low
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose low molecular weight heparin (LLMWH)
Trial: 20356555
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight unfractionated heparin (LLMWUFH)
Trial: 20356555
Drug: High-dose heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose heparin (HH)
Trial: 20356555
Drug: High-dose low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose low molecular weight heparin (HLMWH)
Trial: 10633209
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg of iron per day (nutritional supplement made from bovine blood)
Trial: 7797897
Drug: Bivalent live
RxNorm normalized name: fecal microbiota, live Enema [Rebyota]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalent live attenuated influenza A virus vaccine
Trial: 21658476
Drug: Cognitive Behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavior Therapy for Insomnia (CBT-I)
Trial: 19705924
Drug: Bilastine 5
RxNorm normalized name: bilastine
DrugBank: Bilastine (DB11591)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Bilastine 5 mg
Trial: 16500251
Drug: Johns Hopkins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Johns Hopkins Antibiotic Guide (JHABX) on the RIM Blackberry PDA
Trial: 11575443
Drug: 200 ml
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 ml water containing 10 mg Cu/L (as copper sulfate)
Trial: 11575443
Drug: 200 ml
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 ml distilled water
Trial: 8118750
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) - 2 mg 17 beta-estradiol plus 1 mg norethisterone daily for 1 year
Trial: 8118750
Drug: Nandrolone Decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone Decanoate (ND) - 50 mg i.m. every 3 weeks for 1 year
Trial: 3415895
Drug: MHS(B) -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MHS(B) - morphine hydrogel suppository with high initial release rate
Trial: 3415895
Drug: MHS(S) -
RxNorm normalized name: S-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MHS(S) - morphine hydrogel suppository with constant release rate
Trial: 29231336
Drug: Conventional triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional triple drugs (omeprazole, amoxicillin and clarithromycin) for Hp positive patients, and omeprazole for Hp negative patients
Trial: 25872149
Drug: Single-dose treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose treatment of AM-101
Trial: 25872149
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of AM-101 over 2 weeks
Trial: 25872149
Drug: Three injections
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three injections of AM-101 over 3 consecutive days
Trial: 12956495
Drug: IMZ two-stage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMZ two-stage implants
Trial: 12956495
Drug: ITI one-stage
RxNorm normalized name: Arthur Itis
DrugBank: Trolamine salicylate (DB11079)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ITI one-stage implants
Trial: 8368558
Drug: Total Intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total Intravenous Anesthesia (6.0 mg.kg‐1 x h‐1 propofol)
Trial: 2947345
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (Provera) 20 mg orally thrice daily for one month
Trial: 30257641
Drug: As concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: As concentration >=0.02 mg/kg
Trial: 30257641
Drug: Ni concentration
RxNorm normalized name: Toto ni vavalagi oil
DrugBank: Castor oil (DB11113)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ni concentration >=0.1232 mg/kg
Trial: 30257641
Drug: Se concentration
RxNorm normalized name: Low glucose concentration peritoneal dialysis solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Se concentration >=0.02 mg/kg
Trial: 30257641
Drug: Fe concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fe concentration >=6.9153 mmol/L
Trial: 30257641
Drug: Ni concentration
RxNorm normalized name: Toto ni vavalagi oil
DrugBank: Castor oil (DB11113)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ni concentration >=0.0965 mg/kg
Trial: 28870472
Drug: High β‐glucan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High β‐glucan barley (4.4 g/d)
Trial: 28870472
Drug: High β‐glucan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High β‐glucan barley (4.4 g/d) in subgroup with VFA ≥100 cm2
Trial: 20350051
Drug: Glycyrrhizin salt
RxNorm normalized name: glycyrrhizinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycyrrhizin salt tablet 150 mg twice daily for 14 consecutive days
Trial: 18486720
Drug: Diet and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet and medication therapy to lower urine supersaturation
Trial: 10509788
Drug: Cyclophosphamide (CYCLO)
DrugBank: Cyclophosphamide (DB00531)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cyclophosphamide (CYCLO) at a dose of 1200 mg/m2
Trial: 10509788
Drug: Ifosfamide (IFOS)
RxNorm normalized name: Ifosfamide
DrugBank: Ifosfamide (DB01181)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ifosfamide (IFOS) at a dose of 5 g/m2
Trial: 1781536
Drug: 150 ml
RxNorm normalized name: REBYOTA 150 ML Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 ml of clear fluid 1.5‐2 hours before anaesthesia
Trial: 6792382
Drug: Protein-containing solution
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein-containing solution with hypertonic glucose
Trial: 6792382
Drug: Protein-free solution
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein-free solution
Trial: 30831601
Drug: Current use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current use of soy supplements
Trial: 27256356
Drug: nasally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nasally administered oxytocin
Trial: 19501409
Drug: Topical gatifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical gatifloxacin for 3 days before injection
Trial: 19501409
Drug: Topical gatifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical gatifloxacin in combination with PVI
Trial: 10857960
Drug: KJM fiber-enriched
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KJM fiber-enriched test biscuits (0.5 g of glucomannan per 100 kcal of dietary intake or 8-13 g/day)
Trial: 30548390
Drug: Metformin (n=27)
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin (n=27)
Trial: 30548390
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Metformin and Placebo)
Trial: 29795172
Drug: High-Intensity Interval
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Intensity Interval Training (HIIT) - exercised twice a week at 85–95% of HRmax
Trial: 29795172
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group - treatment as usual
Trial: 27716200
Drug: Internet cognitive-behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet cognitive-behavioural therapy (CBT) with seven experimental factors (activity scheduling, functional analysis, thought challenging, relaxation, concreteness training, absorption, self-compassion training)
Trial: 27716200
Drug: Internet cognitive-behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet cognitive-behavioural therapy (CBT) with seven experimental factors
Trial: 22140146
Drug: Cigarettes with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarettes with 10.1 μg ammonia per cigarette
Trial: 22140146
Drug: Cigarettes with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarettes with 18.9 μg ammonia per cigarette
Trial: 18515949
Drug: Drug-regimens for
RxNorm normalized name: benzphetamine hydrochloride Oral Tablet [Regimex]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-regimens for fracture prevention
Trial: 18515949
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of different drug-regimens
Trial: 16164375
Drug: Non-medical and
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-medical and non-surgical therapies for palliative care
Trial: 29793605
Drug: ABP-700 (infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABP-700 (infusion doses varying, continuous infusion for 30 minutes)
Trial: 29793605
Drug: Propofol (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (60 μg kg-1 min-1)